ReviewDiscover nano2026
Current understanding and future scope of nanotechnology enabled epidermal care using cosmetics and cosmeceuticals.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nanotechnology has a significant role in cosmetics and cosmeceuticals for epidermal care. In this review, mechanisms of nanomaterial penetration into the skin and penetration pathways, key physicochemical factors, as well as the various models, namely in vitro, ex vivo, and in vivo, used to investigate nanoparticle behavior with the epidermis, have been discussed. The roles of nanocarriers and active ingredients have been discussed in the design and development of nanoformulations to address limitations of conventional topical formulations, including poor solubility, instability, and limited skin penetration of active ingredients. Furthermore, they improve skin hydration, promote skin repair, and support anti-aging and antioxidant functions, influencing their effectiveness, along with safety, environmental sustainability, and global regulatory frameworks for nanomaterials in skin care products. Future research should focus on sustainable nanomaterials and advanced toxicological assessment methods to ensure consumer safety without compromising product efficacy. The details of analysis and characterization of active ingredients and nanomaterials-based formulations in epidermal care have been provided. Furthermore, the guidelines from India, the EU, and the USA are briefly provided to support stakeholders. Finally, future research directions are highlighted, with particular emphasis on integrative design strategies that combine experimental evaluation with theoretical and in silico toxicity prediction models to ensure consumer safety while maintaining product efficacy.Clinical trial number: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.